Acasă › Cancer pancreatic › Maryland › Baltimore
Studii clinice pentru Cancer pancreatic în Baltimore, MD
31 studii pentru Cancer pancreatic caută participanți în și în jurul orașului Baltimore (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 2
- Johns Hopkins University, Baltimore
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
În curs de recrutareFaza 3
- Johns Hopkins University, Baltimore
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
În curs de recrutareFaza 2/3
- JHU Oncology Central Kit Services, Baltimore
- Johns Hopkins Hospital, Baltimore
- Oncology Investigational Drug Service (IDS), Baltimore
- și încă 1
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
În curs de recrutareFaza 3
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins & Sibley Memorial Hospital, Baltimore
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
În curs de recrutareFaza 3
- University of Maryland School - Division of Hematology/Oncology, Baltimore
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
În curs de recrutareFaza 1/2
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
În curs de recrutareStudiu observațional
- The Johns Hopkins University School of Medicine, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
În curs de recrutareFaza 1
- Johns Hopkins, Baltimore
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
În curs de recrutareFaza 2
- Johns Hopkins Hospital, Baltimore
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
În curs de recrutareStudiu observațional
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
În curs de recrutare
- Johns Hopkins Hospital, Baltimore
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
În curs de recrutareFaza 2
- Johns Hopkins University, Baltimore
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
În curs de recrutareFaza 3
- Sinai Hospital of Baltimore, Baltimore
Pancreatic Cancer Registry: For Any Person With a Personal or Family History
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Johns Hopkins Hospital, Baltimore
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
În curs de recrutareFaza 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
EXoPERT EMERALD Clinical Study
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- John Hopkins University, Baltimore
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
În curs de recrutareFaza 1Voluntari sănătoși bineveniți
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
În curs de recrutareFaza 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
În curs de recrutareFaza 1/2
- Johns Hopkins Hospital, Baltimore
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
În curs de recrutareFaza 3
- Sinai Hospital of Baltimore, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
În curs de recrutareFaza 1/2
- Johns Hopkins University, Baltimore
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
În curs de recrutareFaza 2
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
În curs de recrutareFaza 1/2
- Johns Hopkins University, Baltimore
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
În curs de recrutareStudiu observațional
- The Johns Hopkins Hospital, Baltimore
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
În curs de recrutareFaza 2
- Ohio State University-Telemedicine, Baltimore
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
În curs de recrutareFaza 1/2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · La 8 mi distanță
The Cancer of the Pancreas Screening-5 CAPS5)Study
În curs de recrutareFaza 3
- Johns Hopkins Hospital, Baltimore
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
În curs de recrutareStudiu observațional
- The Johns Hopkins Hospital, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
În curs de recrutareFaza 1/2
- Johns Hopkins, Baltimore
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
În curs de recrutareStudiu observațional
- Johns Hopkins Hospital, Baltimore
Studii pentru Cancer pancreatic în alte orașe
- Houston, TX61 studii
- New York City, NY60 studii
- Boston, MA43 studii
- Nashville, TN39 studii
- Los Angeles, CA35 studii
- St. Louis, MO33 studii
- Arlington, VA33 studii
- San Antonio, TX31 studii
- Philadelphia, PA26 studii
- Tampa, FL26 studii
- Durham, NC24 studii
- San Diego, CA24 studii
Alte studii în Baltimore
- Cancer pulmonar cu celule non-pătrate60 studii
- Cancer de sân47 studii
- Cancer de prostată43 studii
- Cancer pulmonar40 studii
- Cancer (toate tipurile)37 studii
- Cancer colorectal31 studii
- Cancer metastatic28 studii
- Obezitate26 studii
- Cancer de vezică urinară24 studii
- Insuficiență cardiacă24 studii
- Cancer ovarian22 studii
- Accident vascular cerebral21 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.